Assessment of The Economic Value Of Dpp-4 Inhibitor Alogliptin Compared With Sitagliptin, Saxagliptin, And Linagliptin
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.657
https://www.valueinhealthjournal.com/article/S1098-3015(14)02587-X/fulltext
Section Title :
Disease-Specific Studies
Section Order :
81
First Page :
A337
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02587-X&doi=10.1016/j.jval.2014.08.657